Glycopyrronium Bromide 0.5mg/mL and Neostigmine Metilsulfate 2.5mg/mL Injection New Zealand - engelsk - Medsafe (Medicines Safety Authority)

glycopyrronium bromide 0.5mg/ml and neostigmine metilsulfate 2.5mg/ml injection

max health limited - glycopyrronium bromide 0.5 mg/ml; neostigmine metilsulfate 2.5 mg/ml - solution for injection - active: glycopyrronium bromide 0.5 mg/ml neostigmine metilsulfate 2.5 mg/ml excipient: citric acid citric acid monohydrate dibasic sodium phosphate dodecahydrate sodium hydroxide water for injection - reversal of residual non-depolarising (competitive) neuromuscular block.

Glycopyrronium Bromide 200 micrograms/ml Solution for Injection New Zealand - engelsk - Medsafe (Medicines Safety Authority)

glycopyrronium bromide 200 micrograms/ml solution for injection

max health limited - glycopyrronium bromide 0.2 mg/ml - solution for injection - 0.2 mg/ml - active: glycopyrronium bromide 0.2 mg/ml excipient: hydrochloric acid sodium chloride water for injection - glycopyrrolate is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial and pharyngeal secretions: to reduce the volume and free acidity of gastric secretions and to block cardiac vagal inhibitory reflexes during induction of anaesthesia and intubation when indicated. glycopyrronium bromide 200 micrograms per ml solution for injection may be used intraoperatively to counteract drug-induced or vagal traction reflexes with the associated arrhythmias. glycopyrrolate protects against the peripheral muscarinic effects (e.g. bradycardia and excessive secretions) of cholinergic agents such as neostigmine and pyridostigmine given to reverse the neuromuscular blockade due to non-depolarising muscle relaxants. for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or when oral medication is not tolerated.

Novistig 0.5 mg/ml + 2.5 mg/ml solution for injection Irland - engelsk - HPRA (Health Products Regulatory Authority)

novistig 0.5 mg/ml + 2.5 mg/ml solution for injection

sintetica ireland limited - glycopyrronium bromide; neostigmine metilsulfate - solution for injection - 0.5 mg/ml + 2.5 milligram(s)/millilitre - glycopyrronium bromide

Glycopyrronium Bromide 200 micrograms/ml Solution for Injection Irland - engelsk - HPRA (Health Products Regulatory Authority)

glycopyrronium bromide 200 micrograms/ml solution for injection

mercurypharm ltd - glycopyrronium bromide - solution for injection - 200 microgram(s)/millilitre - synthetic anticholinergics, quaternary ammonium compounds; glycopyrronium bromide

Robinul-Neostigmine 0.5 mg/ml - 2.5 mg/ml inj. sol. i.v. amp. Belgia - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

robinul-neostigmine 0.5 mg/ml - 2.5 mg/ml inj. sol. i.v. amp.

eumedica pharmaceuticals gmbh - neostigmine metilsulfate 2,5 mg/ml; glycopyrronium bromide 0,5 mg/ml - solution for injection - 0,50 mg/ml - 2,50 mg/ml - glycopyrronium bromide 0.5 mg/ml; neostigmine metilsulfate 2.5 mg/ml - glycopyrronium bromide

Glycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg/2.5mg per mL New Zealand - engelsk - Medsafe (Medicines Safety Authority)

glycopyrronium bromide and neostigmine metilsulfate 0.5mg/2.5mg per ml

boucher & muir (nz) ltd t/a mercury pharma (nz) - glycopyrronium bromide 0.5 mg/ml; neostigmine metilsulfate 2.5 mg/ml - solution for injection - active: glycopyrronium bromide 0.5 mg/ml neostigmine metilsulfate 2.5 mg/ml excipient: citric acid citric acid monohydrate dibasic sodium phosphate dodecahydrate sodium hydroxide water for injection - reversal of residual non-depolarising (competitive) neuromuscular block.

Glycopyrronium bromide 200 micrograms/ml Solution for injection Irland - engelsk - HPRA (Health Products Regulatory Authority)

glycopyrronium bromide 200 micrograms/ml solution for injection

martindale pharmaceuticals ltd - glycopyrronium bromide - solution for injection - 200 microgram(s)/millilitre - synthetic anticholinergics, quaternary ammonium compounds; glycopyrronium bromide

Novistig 0.5 mg/ml + 2.5 mg/ml solution for injection Irland - engelsk - HPRA (Health Products Regulatory Authority)

novistig 0.5 mg/ml + 2.5 mg/ml solution for injection

sintetica gmbh - glycopyrronium bromide; neostigmine metilsulfate - solution for injection - glycopyrronium bromide

Glycopyrronium bromide 1mg tablets Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

glycopyrronium bromide 1mg tablets

morningside healthcare ltd - glycopyrronium bromide - oral tablet - 1mg

Glycopyrronium bromide 2mg tablets Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

glycopyrronium bromide 2mg tablets

morningside healthcare ltd - glycopyrronium bromide - oral tablet - 2mg